Clinical Trial Update: Glucagon Ready to Use (RTU) in Subjects With Hyperinsulinemic Hypoglycemia After Bariatric Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Glucagon Ready to Use (RTU) in subjects with hyperinsulinemic hypoglycemia after bariatric surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperinsulinemic Hypoglycemia After Bariatric Surgery

Drugs mentioned

• Glucagon Ready-to-Use (RTU) (glucagon)

Snippet

Sponsor: Xeris Pharmaceuticals | Conditions: Hyperinsulinemic Hypoglycemia | Phase 2 | Status: COMPLETED